SequelSEC

ACCURAY INC ARAY

Surgical & Medical Instruments & Apparatus · CIK 0001138723 · Fiscal year ends 0630

AnnualQuarterlyTTM
Revenue
$401.95M
Fiscal year ended 2026-06-30
Operating income
-$26.44M
Fiscal year ended 2026-06-30
Free cash flow
-$12.84M
Fiscal year ended 2026-06-30

Valuation, from the filing

Public float$86.94MMarket value of stock held by non-affiliates, as stated on the cover page for 2025-12-31
Float per share$0.73Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself.
Float / revenue0.2×A lower bound on the multiple, because affiliate holdings are excluded.
Float / equity2.1×A lower bound on the multiple, because affiliate holdings are excluded.

Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2025-12-31, not today, and each multiple below it uses the figures for the fiscal year ending 2026-06-30 — the year that filing covered.

How this compares in its industry

Percentile among the Surgical & Medical Instruments & Apparatus filers on this site, highest value first. A high percentile means a large figure, which is good for a margin and not for leverage — the ranking says where the company sits, not whether that is where it should be.

MeasureReportedPercentile
Long-term debt / equity3.51x96th
Gross margin27.7%11th
Revenue YoY growth-12.3%12th
SBC / revenue1.6%19th
Current ratio1.50x25th
CapEx / revenue1.5%32th
Operating margin-6.6%63th
R&D / revenue9.4%41th
Net margin-12.2%58th
FCF margin-3.2%57th

ACCURAY INC (ARAY) reported revenue of $401.95M and net income of -$49.19M for the fiscal year ended 2026-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from ACCURAY INC’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Surgical & Medical Instruments & Apparatus.

Income

ACCURAY INC income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Revenue$401.95M
Cost of revenue$290.96M
Gross profit$110.99M
Operating income-$26.44M
Net income-$49.19M
Research & development$37.90M
Weighted-average diluted sharesUnavailable
Pretax income-$47.25M
Income tax expense$1.95M
Diluted EPSUnavailable
Selling, general & administrative$86.17M
General & administrative$47.32M
Selling & marketing$38.85M

Balance

ACCURAY INC balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Cash & equivalents$40.62M
Total assets$443.68M
Current assets$287.78M
Total liabilities$401.98M
Current liabilities$191.40M
Total equity incl. NCI$41.70M
Temporary (mezzanine) equityUnavailable
Inventory$147.08M
Accounts receivable$67.41M
Goodwill$57.91M
Long-term debt$146.37M
Accounts payable$40.55M

Cash flow

ACCURAY INC cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Operating cash flow-$6.98M
Capital expenditures$5.86M
Investing cash flow-$12.28M
Financing cash flow$6.98M
Net change in cash-$13.37M
Stock-based compensation$6.46M
Common dividends paidUnavailable
Common share repurchasesUnavailable
Depreciation & amortization$7.94M

Derived

ACCURAY INC derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Free cash flow-$12.84M
Gross margin27.6%
Operating margin-6.6%
FCF margin-3.2%
SBC / revenue1.6%
Current ratio1.50x
Revenue YoY growth-12.3%
Net margin-12.2%
R&D / revenue9.4%
CapEx / revenue1.5%
Long-term debt / equity3.51x
Effective tax rateUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open ARAY in the interactive workspace to inspect any figure back to its filing.

Source filings

10-K · Filed 2026-08-27View SEC filing
10-Q · Filed 2026-05-06View SEC filing
10-K/A · Filed 2026-02-17View SEC filing
10-Q/A · Filed 2026-02-17View SEC filing
10-Q · Filed 2026-02-17View SEC filing
10-Q · Filed 2025-11-05View SEC filing

Companies in the same industry

ADGM AEMD ALUR AMIX ANGO ANIK AORT APYX ATEC ATRC AURX BAX

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.